Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Plos One|October 25, 2011
Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interactionChristopher J Scarlett, Emily K Colvin, Mark Pinese, et al.
BJU International|October 14, 2011
High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapyRichard Savdie, Lisa G Horvath, Ruth Pe Benito, et al.
BMC Cancer|September 11, 2012
RON is not a prognostic marker for resectable pancreatic cancerCarole M Tactacan, David K Chang, Mark J Cowley, et al.
International Journal of Oncology|February 20, 2015
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivoJohana M Susanto, Emily K Colvin, Mark Pinese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitroLisa G Horvath, Susan M Henshall, James G Kench, et al.
Molecular Cancer Therapeutics|September 21, 2006
A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cellsAlison J Butt, Caroline G Roberts, Alan A Seawright, et al.
Molecular and Cellular Biology|November 21, 2012
TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancersBenjamin J Shields, Florian Wiede, Esteban N Gurzov, et al.
BJU International|November 8, 2007
The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levelsGianluca Severi, Vanessa M Hayes, Andrea A Tesoriero, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
Cancer Research|September 24, 2009
Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profilingLiangli Zhao, Brian Y Lee, David A Brown, et al.
Pageof 16